Name: Safety Aspects of Omeprazole
Creator: Lennart Sölvell
Keywords: Zollinger-Ellison Syndrome, Peptic Ulcer, 03 medical and health sciences, 0302 clinical medicine, Dose-Response Relationship, Drug, Creatinine, Humans, Alanine Transaminase, Benzimidazoles, Female

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 1986 English Publisher:Informa UK LimitedJournal:Scandinavian Journal of Gastroenterology, volume 21, pages 129-133 (issn: 0036-5521, eissn: 1502-7708,

Authors: Lennart Sölvell;

doi: 10.3109/00365528609090915

pmid: 3460168

Safety Aspects of Omeprazole

- Summary
- Subjects
- Metrics

Abstract

Omeprazole has been given to more than 2500 subjects, mostly in short-term studies for 2-4 weeks, but also to some patients for more than 2 years. An analysis of side-effects has so far not shown a specific pattern that could be attributed to the drug.

Keywords

Zollinger-Ellison Syndrome, Peptic Ulcer, Dose-Response Relationship, Drug, Creatinine, Humans, Alanine Transaminase, Benzimidazoles, Female, Anti-Ulcer Agents, Omeprazole

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	9
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average